Waters Corporation

NYSE WAT

Download Data

Waters Corporation Market Capitalization on June 03, 2024: USD 18.38 B

Waters Corporation Market Capitalization is USD 18.38 B on June 03, 2024, a 20.27% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Waters Corporation 52-week high Market Capitalization is USD 21.46 B on May 15, 2024, which is 16.74% above the current Market Capitalization.
  • Waters Corporation 52-week low Market Capitalization is USD 14.00 B on October 30, 2023, which is -23.87% below the current Market Capitalization.
  • Waters Corporation average Market Capitalization for the last 52 weeks is USD 17.56 B.
NYSE: WAT

Waters Corporation

CEO Dr. Udit Batra Ph.D.
IPO Date Nov. 16, 1995
Location United States
Headquarters 34 Maple Street, Milford, MA, United States, 01757
Employees 7,900
Sector Healthcare
Industry Diagnostics & research
Description

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Similar companies

IDXX

IDEXX Laboratories Inc

USD 492.43

-0.91%

CRL

Charles River Laboratories

USD 207.93

-0.24%

RVTY

Revvity Inc.

USD 108.80

-0.42%

DHR

Danaher Corporation

USD 261.38

1.78%

TWST

Twist Bioscience Corp

USD 44.01

5.04%

ICLR

ICON PLC

USD 323.49

-0.41%

StockViz Staff

September 8, 2024

Any question? Send us an email